Lena Söderström steps down from Isconova
This article was originally published in Scrip
Lena Söderström, chief executive officer of Isconova, is to leave the company on 1 October 2011 after two years' service. Russell Greig, one of Isconova's board members will take the role of acting CEO during the recruitment process. Mr Greig has more than 30 years' experience in the pharmaceutical industry, having most recently served as president of SR One, GlaxoSmithKline's corporate venture group.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.